SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-006911
Filing Date
2024-05-07
Accepted
2024-05-07 07:45:44
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20240331x10q.htm   iXBRL 10-Q 1091436
2 EX-31.1 cgtx-20240331xex31d1.htm EX-31.1 16705
3 EX-31.2 cgtx-20240331xex31d2.htm EX-31.2 16994
4 EX-32.1 cgtx-20240331xex32d1.htm EX-32.1 10060
5 EX-32.2 cgtx-20240331xex32d2.htm EX-32.2 10048
  Complete submission text file 0001558370-24-006911.txt   4913648

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20240331.xsd EX-101.SCH 33234
7 EX-101.CAL cgtx-20240331_cal.xml EX-101.CAL 39434
8 EX-101.DEF cgtx-20240331_def.xml EX-101.DEF 133145
9 EX-101.LAB cgtx-20240331_lab.xml EX-101.LAB 340285
10 EX-101.PRE cgtx-20240331_pre.xml EX-101.PRE 256186
63 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20240331x10q_htm.xml XML 705144
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 24919662
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)